SynthesisActa diabetologica2025

Revisiting the markers interleukin-6 and glucagon-like peptide-1 for targeting low-grade inflammation in type 2 diabetes: a meta-analysis and our lab experience.

Jyoti Kiran Bara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.